Transfusion Approaches and Mortality in Trauma Patients: A Narrative Review

Abstract

Trauma is one of the leading causes of mortality in the world, accounting for millions of deaths per year. One of the most frequent causes of death in trauma patients is hemorrhage. The presence of a coagulopathy in trauma patients more than doubles the expected mortality. Coagulation management is a key aspect of care for bleeding trauma patients and has been investigated in many studies. However, it is unclear whether a particular approach to coagulation management is associated with a reduction in mortality. Treatment may be guided (e.g., viscoelastic test-guided administration of coagulation factor concentrates) or nonguided (e.g., treatment with a fixed ratio of plasma:red blood cells). This review aimed to assess the published literature regarding coagulation management technique and mortality rate. From the 41 articles obtained in the literature search, there appeared to be a trend toward lower mortality in studies utilizing a guided approach, despite a higher injury severity score in these patients. There were many methodological variations across studies including coagulation management approaches, inclusion criteria, time and type of measurements, use of early fast coagulation monitoring and damage control surgery principles, additional products to those under study, and potential regional differences. It is essential that controlled trials are performed to ascertain optimal transfusion approaches in trauma patients.

Keywords

trauma - coagulation - hemostasis - mortality - transfusion

• References

• 1 World Health Organization. Injuries and Violence: The Facts. 2014
• 2 Gmür J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 1991; 338 (8777): 1223-1226
• 3 Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006; 60 (6, Suppl): S3-S11
• 4 Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003; 54 (06) 1127-1130
• 5 Maegele M, Lefering R, Yucel N. , et al; AG Polytrauma of the German Trauma Society (DGU). Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 2007; 38 (03) 298-304
• 6 MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma 2003; 55 (01) 39-44
• 7 Rossaint R, Bouillon B, Cerny V. , et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care 2016; 20 (01) 100
• 8 Kelly JM, Callum JL, Rizoli SB. 1:1:1 - Warranted or wasteful? Even where appropriate, high ratio transfusion protocols are costly: early transition to individualized care benefits patients and transfusion services. Expert Rev Hematol 2013; 6 (06) 631-633
• 9 Guidry C, DellaVope J, Simms E. , et al. Impact of inverse ratios on patients with exsanguinating vascular injuries: should more be the new paradigm?. J Trauma Acute Care Surg 2013; 74 (02) 403-409 , discussion 409–410
• 10 Davenport R, Curry N, Manson J. , et al. Hemostatic effects of fresh frozen plasma may be maximal at red cell ratios of 1:2. J Trauma 2011; 70 (01) 90-95 , discussion 95–96
• 11 Duchesne JC, Heaney J, Guidry C. , et al. Diluting the benefits of hemostatic resuscitation: a multi-institutional analysis. J Trauma Acute Care Surg 2013; 75 (01) 76-82
• 12 Snyder CW, Weinberg JA, McGwin Jr G. , et al. The relationship of blood product ratio to mortality: survival benefit or survival bias?. J Trauma 2009; 66 (02) 358-362 , discussion 362–364
• 13 Magnotti LJ, Zarzaur BL, Fischer PE. , et al. Improved survival after hemostatic resuscitation: does the emperor have no clothes?. J Trauma 2011; 70 (01) 97-102
• 14 Holcomb JB, del Junco DJ, Fox EE. , et al; PROMMTT Study Group. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 2013; 148 (02) 127-136
• 15 Holcomb JB, Tilley BC, Baraniuk S. , et al; PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015; 313 (05) 471-482
• 16 Schöchl H, Nienaber U, Maegele M. , et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15 (02) R83
• 17 Schöchl H, Schlimp CJ. Trauma bleeding management: the concept of goal-directed primary care. Anesth Analg 2014; 119 (05) 1064-1073
• 18 Innerhofer P, Fries D, Mittermayr M. , et al. Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol 2017; 4 (06) e258-e271
• 19 Innerhofer P, Westermann I, Tauber H. , et al. The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 2013; 44 (02) 209-216
• 20 Gonzalez E, Moore EE, Moore HB. , et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg 2016; 263 (06) 1051-1059
• 21 Schlimp CJ, Voelckel W, Inaba K, Maegele M, Schöchl H. Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/- fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: a retrospective study. Scand J Trauma Resusc Emerg Med 2013; 21: 74
• 22 Schöchl H, Nienaber U, Hofer G. , et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14 (02) R55-R55
• 23 Schöchl H, Voelckel W, Maegele M, Kirchmair L, Schlimp CJ. Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients. Crit Care 2014; 18 (04) R147
• 24 Nakstad AR, Skaga NO, Pillgram-Larsen J, Gran B, Heier HE. Trends in transfusion of trauma victims--evaluation of changes in clinical practice. Scand J Trauma Resusc Emerg Med 2011; 19: 23
• 25 Dirks J, Jørgensen H, Jensen CH, Ostrowski SR, Johansson PI. Blood product ratio in acute traumatic coagulopathy–effect on mortality in a Scandinavian level 1 trauma centre. Scand J Trauma Resusc Emerg Med 2010; 18: 65
• 26 Rizoli SB, Scarpelini S, Callum J. , et al. Clotting factor deficiency in early trauma-associated coagulopathy. J Trauma 2011; 71 (05) (Suppl. 01) S427-S434
• 27 Mahambrey TD, Fowler RA, Pinto R. , et al. Early massive transfusion in trauma patients: Canadian single-centre retrospective cohort study. Can J Anaesth 2009; 56 (10) 740-750
• 28 Guidry C, Gleeson E, Simms ER. , et al. Initial assessment on the impact of crystalloids versus colloids during damage control resuscitation. J Surg Res 2013; 185 (01) 294-299
• 29 Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE. Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. JAMA Surg 2013; 148 (03) 218-225
• 30 Sawhney C, Kaur M, Gupta B. , et al. Critical care issues in solid organ injury: Review and experience in a tertiary trauma center. Saudi J Anaesth 2014; 8 (Suppl. 01) S29-S35
• 31 Mitra B, Cameron PA, Mori A, Fitzgerald M. Acute coagulopathy and early deaths post major trauma. Injury 2012; 43 (01) 22-25
• 32 Johansson PI, Sørensen AM, Perner A. , et al. Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. Crit Care 2011; 15 (06) R272
• 33 Mutschler M, Nienaber U, Münzberg M. , et al; TraumaRegister DGU. The Shock Index revisited - a fast guide to transfusion requirement? A retrospective analysis on 21,853 patients derived from the TraumaRegister DGU. Crit Care 2013; 17 (04) R172
• 34 Perel P, Clayton T, Altman DG. , et al; PROGRESS Partnership. Red blood cell transfusion and mortality in trauma patients: risk-stratified analysis of an observational study. PLoS Med 2014; 11 (06) e1001664
• 35 Mutschler M, Nienaber U, Wafaisade A. , et al; TraumaRegister DGU®. The impact of severe traumatic brain injury on a novel base deficit- based classification of hypovolemic shock. Scand J Trauma Resusc Emerg Med 2014; 22: 28
• 36 Cap AP, Spinella PC, Borgman MA, Blackbourne LH, Perkins JG. Timing and location of blood product transfusion and outcomes in massively transfused combat casualties. J Trauma Acute Care Surg 2012; 73 (02) (Suppl. 01) S89-S94
• 37 Wafaisade A, Lefering R, Maegele M. , et al; Trauma Registry of DGU. Coagulation management of bleeding trauma patients is changing in German trauma centers: an analysis from the trauma registry of the German Society for Trauma Surgery. J Trauma Acute Care Surg 2012; 72 (04) 936-942
• 38 Harvey MP, Greenfield TP, Sugrue ME, Rosenfeld D. Massive blood transfusion in a tertiary referral hospital. Clinical outcomes and haemostatic complications. Med J Aust 1995; 163 (07) 356-359
• 39 Fuller G, Bouamra O, Woodford M. , et al. Recent massive blood transfusion practice in England and Wales: view from a trauma registry. Emerg Med J 2012; 29 (02) 118-123
• 40 Engels PT, Rezende-Neto JB, Al Mahroos M, Scarpelini S, Rizoli SB, Tien HC. The natural history of trauma-related coagulopathy: implications for treatment. J Trauma 2011; 71 (05) (Suppl. 01) S448-S455
• 41 Dzik WS, Ziman A, Cohen C. , et al; Biomedical Excellence for Safer Transfusion Collaborative. Survival after ultramassive transfusion: a review of 1360 cases. Transfusion 2016; 56 (03) 558-563
• 42 González-Guerrero C, Lozano-Andreu T, Roch-Santed M. , et al. Evaluation of the efficiency under current use of human fibrinogen concentrate in trauma patients with life-threatening hemorrhagic disorders. Blood Coagul Fibrinolysis 2017; 28 (01) 66-71
• 43 Henriksen HH, Rahbar E, Baer LA. , et al. Pre-hospital transfusion of plasma in hemorrhaging trauma patients independently improves hemostatic competence and acidosis. Scand J Trauma Resusc Emerg Med 2016; 24 (01) 145
• 44 Olaussen A, Fitzgerald MC, Tan GA, Mitra B. Cryoprecipitate administration after trauma. Eur J Emerg Med 2016; 23 (04) 269-273
• 45 Wafaisade A, Lefering R, Maegele M. , et al; Trauma Registry of DGU. Administration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at discharge. J Trauma Acute Care Surg 2013; 74 (02) 387-3 , discussion 393–395
• 46 Peden M, McGee K, Sharma G. The Injury Chart Book: A Graphical Overview of the Global Burden of Injuries. Geneva: World Health Organization; 2002
• 47 Zielinski MD, Jenkins DH, Hughes JD, Badjie KS, Stubbs JR. Back to the future: the renaissance of whole-blood transfusions for massively hemorrhaging patients. Surgery 2014; 155 (05) 883-886
• 48 Watson GA, Sperry JL, Rosengart MR. , et al; Inflammation and Host Response to Injury Investigators. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 2009; 67 (02) 221-227 , discussion 228–230
• 49 Inaba K, Branco BC, Rhee P. , et al. Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg 2010; 210 (06) 957-965
• 50 Sarani B, Dunkman WJ, Dean L, Sonnad S, Rohrbach JI, Gracias VH. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 2008; 36 (04) 1114-1118
• 51 Khan H, Belsher J, Yilmaz M. , et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007; 131 (05) 1308-1314
• 52 Li G, Rachmale S, Kojicic M. , et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion 2011; 51 (02) 338-343
• 53 Allen CJ, Shariatmadar S, Meizoso JP. , et al. Liquid plasma use during “super” massive transfusion protocol. J Surg Res 2015; 199 (02) 622-628
• 54 Ives C, Inaba K, Branco BC. , et al. Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma. J Am Coll Surg 2012; 215 (04) 496-502
• 55 Johansson PI, Sørensen AM, Larsen CF. , et al. Low hemorrhage-related mortality in trauma patients in a Level I trauma center employing transfusion packages and early thromboelastography-directed hemostatic resuscitation with plasma and platelets. Transfusion 2013; 53 (12) 3088-3099
• 56 Khan S, Brohi K, Chana M. , et al; International Trauma Research Network (INTRN). Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. J Trauma Acute Care Surg 2014; 76 (03) 561-567 , discussion 567–568
• 57 Rourke C, Curry N, Khan S. , et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10 (07) 1342-1351